Cite
Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine.
MLA
Wakasugi, S., et al. “Detection of Abnormal Cardiac Adrenergic Neuron Activity in Adriamycin-Induced Cardiomyopathy with Iodine-125-Metaiodobenzylguanidine.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 33, no. 2, Feb. 1992, pp. 208–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1732442&authtype=sso&custid=ns315887.
APA
Wakasugi, S., Wada, A., Hasegawa, Y., Nakano, S., & Shibata, N. (1992). Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 33(2), 208–214.
Chicago
Wakasugi, S, A Wada, Y Hasegawa, S Nakano, and N Shibata. 1992. “Detection of Abnormal Cardiac Adrenergic Neuron Activity in Adriamycin-Induced Cardiomyopathy with Iodine-125-Metaiodobenzylguanidine.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 33 (2): 208–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=1732442&authtype=sso&custid=ns315887.